Client wants to develop a model that has logo only and two pills encased in an acrylic cube, if we list the dosage strength, does it need PAAB review?
Jennifer Carroll last edited by
Question 619 states NOC/c but can be extrapolated to NOC products as well. If the logo and model do not have implications for therapeutic use, the piece could be considered exempt. 496 addresses inclusion of pill visuals for further clarification. We would also advise consulting with the Innovative Medicines Canada Code of Ethical Practices about branding models.